Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
A new study identified compounds within a “failed” tuberculosis treatment that effectively fight some herbicide-resistant “superweeds” in Australia. Researchers say their findings could be a “game-changer for the agriculture sector.”
Customers have reported a 55-percent reduction in the use of antibiotics as a result of the new technology.
Country music artist Bobby Marquez helps host the annual event. Marquez also joined RFD-TV’s own Susanne Alexander in the studio for an update on the event as well as his other latest projects.
A new study from the University of California shows E-15 provides more emissions reductions compared to other blends of gasoline on the market.
